1.00 / AMA PRA Category 1 Credit(s)TM 1.00 / CE for Nurses (0.40 pharmacotherapy credits) (must claim full credit) 1.00 / CE for Psychologists (must claim full credit)
This activity offers ACPE credit for pharmacists; however, ACPE credit is not available via this website. If you are seeking pharmacy credit, please check back for a valid link to view the activity on www.cmeuniversity.com in the near future.
Jointly provided by Postgraduate Institute for Medicine (PIM) and Global Medical Education
This activity is supported by an independent educational grant from Neurocrine Biosciences.
This activity highlights the latest advances in diagnostic and therapeutic issues in patients with tardive dyskinesia (TD). This will include reasons for missed diagnosis, changes in DSM-5, and comorbidities. The latest advances in treating all phases of the illness, including treatment resistant patients, non-pharmacological therapies, side effects of psychotropics, and strategies to make patients active collaborators in their care, will be discussed.
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, pharmacists, registered nurses, psychologists, social workers, and other healthcare professionals who treat patients with psychiatric illnesses.
Upon completion of the activity, participants should be better able to:
Discuss the diagnosis and management of TD in psychiatric patients
Identify psychiatric patients at risk for TD, during routine examinations
Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics
Formulate appropriate treatment regimens considering the emergence of new investigative agents
Conflict Of Interest Disclosure Policy
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
John M. Kane, MD Chairman of Psychiatry Hofstra Northwell School of Medicine Hempstead, NY
Dr. Kane disclosed the following: Consultant: Alkermes, Intracellular Therapies, Lundbeck, Neurocrine, Otsuka, Pierre Fabre, Takeda, Teva Speaker’s Bureau: Alkermes, Eli Lilly, EnVivo Pharmaceuticals (Forum), Forest (Allergan), Genentech, Lundbeck, Intracellular Therapies, Janssen, Johnson & Johnson, Neurocrine, Otsuka, Pierre Fabre, Reviva, Roche, Sunovion, Takeda, Teva Research Support: Janssen, Otsuka Stock Ownership: MedAvante, LB Pharma, Vanguard Research Group
Accredited Provider Disclosures
The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN, and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Publishing Staff Disclosures
Prakash Masand, MD, of Global Medical Education, has the following disclosures: Consultant: Allergan, Lundbeck, Merck, Otsuka, Pfizer, Sunovion, and Takeda Research Support: Allergan and Merck Speaker’s Bureau: Allergan, GlaxoSmithKline, Lundbeck, Merck, Otsuka, Pfizer, Sunovion, and Takeda
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Global Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurses
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 1.00 contact hours is provided by Postgraduate Institute for Medicine. Designated for 0.40 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.
CE for Psychologists
Postgraduate Institute for Medicine (PIM) is approved by the American Psychological Association to sponsor continuing education for psychologists. PIM maintains responsibility for this program and its content.
This program offers 1.00 continuing education credits for psychologists.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.